Algernon Pharmaceuticals (AGNPF) Expected to Announce Earnings on Monday

Algernon Pharmaceuticals (OTCMKTS:AGNPF) is anticipated to post its results after the market closes on Monday, April 27th. Analysts expect Algernon Pharmaceuticals to post earnings of ($0.4976) per share for the quarter.

Algernon Pharmaceuticals Stock Performance

Shares of OTCMKTS AGNPF opened at $0.04 on Monday. The firm’s fifty day moving average is $0.03 and its two-hundred day moving average is $0.05. Algernon Pharmaceuticals has a 52-week low of $0.02 and a 52-week high of $0.07.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel, small-molecule therapeutics. The company’s primary strategy centers on repurposing known compounds with established safety profiles to address unmet medical needs, particularly in the realms of pulmonary fibrosis, acute lung injury and central nervous system (CNS) disorders. By leveraging existing pharmacology data, Algernon aims to accelerate its development timelines while managing costs and risks typically associated with early-stage drug discovery.

The lead asset in Algernon’s pipeline is NP-120 (ifenprodil), an orally available small molecule being investigated for idiopathic pulmonary fibrosis (IPF).